SANARIA INC has a total of 76 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2003. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are PBL MFG LTD, TIANJIN RUIBEITE TECHNOLOGY DEV CO LTD and SERES HEALTH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 21 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | African Regional Industrial Property Organization | 4 | |
#6 | Canada | 4 | |
#7 | Israel | 4 | |
#8 | Singapore | 4 | |
#9 | Brazil | 3 | |
#10 | China | 3 | |
#11 | Japan | 3 | |
#12 | Republic of Korea | 3 | |
#13 | Hong Kong | 2 | |
#14 | South Africa | 2 | |
#15 | New Zealand | 1 | |
#16 | African Intellectual Property Organization | 1 | |
#17 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Biotechnology | |
#4 | Measurement | |
#5 | Agriculture | |
#6 | Basic materials chemistry | |
#7 | Chemical engineering | |
#8 | Packaging and shipping |
# | Name | Total Patents |
---|---|---|
#1 | Hoffman Stephen L | 57 |
#2 | Stafford Richard E | 23 |
#3 | Li Minglin | 21 |
#4 | Sim B Kim Lee | 21 |
#5 | Luke Thomas C | 16 |
#6 | Eappen Abraham G | 13 |
#7 | Seder Robert | 6 |
#8 | Felgner Philip | 6 |
#9 | Van Schaijk Ben | 4 |
#10 | Sauerwein Robert | 4 |
Publication | Filing date | Title |
---|---|---|
US2021045375A1 | Apparatus and Method of Use for an Automated Mosquito Salivary Gland Extraction Device | |
WO2021011503A1 | Mosquito egg cryopreservation | |
US2018306493A1 | Cryovial Storage System | |
US2017355951A1 | Mosquito salivary gland extraction device and methods of use | |
US2016320404A1 | Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines | |
AU2015252843A1 | Infectious Plasmodium sporozoites grown in vitro | |
WO2015031904A2 | Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines | |
US2015313980A1 | Genetic attenuation of Plasmodium by B9 gene disruption | |
US2014120138A1 | Pharmaceutical compositions comprising attenuated Plasmodium sporozoites and glycolipid adjuvants | |
AU2013203625A1 | Purified plasmodium and vaccine compositions - D2 | |
CA2749262A1 | Purified plasmodium and vaccine compositions | |
CN1934448A | Method for the prevention of malaria | |
EP1492402A2 | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |